TGFB1 and neoplasm: In endometrial cancer, enhanced activity of the TGF-β/Smad pathway is correlated with tumor progression, metastasis, and recurrence (112), and its implication in the malignant phenotype of endometrial tumors also promotes cell stemness (113, 114).